Zhu H - Search Results

1

SRPX2 Promotes Tumor Proliferation and Migration via the FAK Pathway in Papillary Thyroid Carcinoma.

Luo N, Tan Y, Deng H, Wu W, Mei L, Huang X, Qin Y, Zhu H, Liu C. Luo N, et al. Among authors: zhu h. J Oncol. 2022 Nov 3;2022:5821545. doi: 10.1155/2022/5821545. eCollection 2022. J Oncol. 2022. PMID: 36385962 Free PMC article.

2

The Biogenesis and Functions of circRNAs and Their Roles in Breast Cancer.

Tang L, Jiang B, Zhu H, Gao T, Zhou Y, Gong F, He R, Xie L, Li Y. Tang L, et al. Among authors: zhu h. Front Oncol. 2021 Feb 25;11:605988. doi: 10.3389/fonc.2021.605988. eCollection 2021. Front Oncol. 2021. PMID: 33718157 Free PMC article. Review.

3

Identification of Molecular Subtypes and Potential Small-Molecule Drugs for Esophagus Cancer Treatment Based on m⁶A Regulators.

Li J, Zhu H, Yang Q, Xiao H, Wu H, Fang Z, Li W, Cai M. Li J, et al. Among authors: zhu h. J Oncol. 2022 Jan 13;2022:5490461. doi: 10.1155/2022/5490461. eCollection 2022. J Oncol. 2022. PMID: 35069736 Free PMC article.

4

DIRAS2 Is a Prognostic Biomarker and Linked With Immune Infiltrates in Melanoma.

Xue W, Zhu H, Liu H, He H. Xue W, et al. Among authors: zhu h. Front Oncol. 2022 May 16;12:799185. doi: 10.3389/fonc.2022.799185. eCollection 2022. Front Oncol. 2022. PMID: 35651810 Free PMC article.

5

Circ0038632 modulates MiR-186/DNMT3A axis to promote proliferation and metastasis in osteosarcoma.

Tan X, Zeng C, Li H, Tan Y, Zhu H. Tan X, et al. Among authors: zhu h. Front Oncol. 2022 Aug 18;12:939994. doi: 10.3389/fonc.2022.939994. eCollection 2022. Front Oncol. 2022. PMID: 36059626 Free PMC article.

6

miR-187/PDLIM1 Gets Involved in Gastric Cancer Progression and Cisplatin Sensitivity of Cisplatin by Mediating the Hippo-YAP Signaling Pathway.

Tan Y, Li Y, Zhu H, Wu X, Mei K, Li P, Yang Q. Tan Y, et al. Among authors: zhu h. J Oncol. 2022 Sep 17;2022:5456016. doi: 10.1155/2022/5456016. eCollection 2022. J Oncol. 2022. PMID: 36164345 Free PMC article.

7

Efficacy and safety of different PD-1 inhibitors in combination with lenvatinib in the treatment of unresectable primary liver cancer: a multicentre retrospective study.

Li QM, Sun QC, Jian Y, He JZ, Zhu HB, Hong C, Zeng L, Li RN, Wang JR, Li Y, Chen LY, Weng X, Liu L, Dong HZ, Xiao LS, Cui H. Li QM, et al. Among authors: zhu hb. Discov Oncol. 2023 Jun 19;14(1):105. doi: 10.1007/s12672-023-00708-0. Discov Oncol. 2023. PMID: 37336826 Free PMC article.

8

Phage display screening identifies a prostate specific antigen (PSA)^-/lo prostate cancer cell specific peptide to retard castration resistance of prostate cancer.

Sui Y, Zhu R, Hu W, Zhang W, Zhu H, Gong M, Gao L, Cao T, Tang T, Yu B, Yang T. Sui Y, et al. Among authors: zhu r, zhu h. Transl Oncol. 2021 Mar;14(3):101020. doi: 10.1016/j.tranon.2021.101020. Epub 2021 Jan 26. Transl Oncol. 2021. PMID: 33508757 Free PMC article.

9

De Novo Mutation in Non-Tyrosine Kinase Domain of ROS1 as a Potential Predictor of Immune Checkpoint Inhibitors in Melanoma.

Ma SC, Zhu HB, Wang J, Zhang YP, Guo XJ, Long LL, Guo ZQ, Wu DH, Dong ZY, Bai X. Ma SC, et al. Front Oncol. 2021 Jun 17;11:666145. doi: 10.3389/fonc.2021.666145. eCollection 2021. Front Oncol. 2021. PMID: 34221982 Free PMC article.

10

Long non-coding RNA MIAT is estrogen-responsive and promotes estrogen-induced proliferation in ER-positive breast cancer cells.

Li Y, Jiang B, Wu X, Huang Q, Chen W, Zhu H, Qu X, Xie L, Ma X, Huang G. Li Y, et al. Among authors: zhu h. Biochem Biophys Res Commun. 2018 Sep 3;503(1):45-50. doi: 10.1016/j.bbrc.2018.05.146. Epub 2018 Jun 15. Biochem Biophys Res Commun. 2018. PMID: 29792859

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30,340 results

Search Page

Filters